ADNP and neurodegenerative disease: For example, the NAP peptide (NAPVSIPQ), derived from the activity-dependent neuroprotective protein (ADNP) [1], has shown efficacy in in vitro as well as in vivo models of neurodegenerative diseases [2, 3].